Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage

[1]  M. Frosch,et al.  Different microvascular alterations underlie microbleeds and microinfarcts , 2019, Annals of neurology.

[2]  M. Frosch,et al.  Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy , 2019, Stroke.

[3]  A. Khakoo,et al.  Utility of Glycosylated TIMP3 molecules: Inhibition of MMPs and TACE to improve cardiac function in rat myocardial infarct model , 2018, Pharmacology research & perspectives.

[4]  F. Verhey,et al.  Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage , 2018, Front. Neurol..

[5]  H. Vinters,et al.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier , 2018, Neurobiology of Aging.

[6]  Shuang Song,et al.  Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk , 2018, Experimental biology and medicine.

[7]  S. Greenberg,et al.  The growing clinical spectrum of cerebral amyloid angiopathy , 2017, Current opinion in neurology.

[8]  Eric E. Smith,et al.  The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  S. Takeda,et al.  Cerebral amyloid angiopathy initially occurs in the meningeal vessels , 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.

[10]  J. Attems,et al.  Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy , 2016, Neuropathology and applied neurobiology.

[11]  M. Frosch,et al.  Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy , 2016, Acta Neuropathologica.

[12]  A. Hartz,et al.  Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  F. Sharp,et al.  Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke , 2016, Front. Cell. Neurosci..

[14]  M. Frosch,et al.  Matrix metalloproteinase 9–mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy , 2015, Neurobiology of Aging.

[15]  C. Bouras,et al.  No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy , 2015, Acta neuropathologica communications.

[16]  Jean-Claude Baron,et al.  Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions. , 2015, Brain : a journal of neurology.

[17]  J. Montaner,et al.  Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9* , 2015, The Journal of Biological Chemistry.

[18]  M. Yamada.  Cerebral Amyloid Angiopathy: Emerging Concepts , 2015, Journal of stroke.

[19]  Michael E. Hall,et al.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. , 2013, Physiology.

[20]  A. Joutel,et al.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.

[21]  S. Manjila,et al.  Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management. , 2012, Neurosurgical focus.

[22]  À. Rovira,et al.  MMP‐2/MMP‐9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy‐Associated Hemorrhagic Stroke , 2012, Brain pathology.

[23]  Ivan Mihaljevic,et al.  Amyloid-&bgr; Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy , 2012, Stroke.

[24]  Anand Viswanathan,et al.  Cerebral amyloid angiopathy in the elderly , 2011, Annals of neurology.

[25]  Colin Smith,et al.  The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  F. Schlachetzki,et al.  Amyloid- Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy , 2011 .

[27]  Jiping Qi,et al.  Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: A postmortem study , 2010, Brain Research.

[28]  I. McKeith,et al.  Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.

[29]  A. Padovani,et al.  Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. , 2009, Current medicinal chemistry.

[30]  J. Montaner,et al.  Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases , 2008, Intensive Care Medicine.

[31]  K. Jellinger,et al.  Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy , 2008, Journal of Neurology.

[32]  Stian Sjøli,et al.  Biological and Pathobiological Functions of Gelatinase Dimers and Complexes , 2008, Connective tissue research.

[33]  M. Wiesmann,et al.  Subarachnoid Hemosiderosis and Superficial Cortical Hemosiderosis in Cerebral Amyloid Angiopathy , 2008, American Journal of Neuroradiology.

[34]  M. Cookson,et al.  The Metalloprotease Inhibitor TIMP-3 Regulates Amyloid Precursor Protein and Apolipoprotein E Receptor Proteolysis , 2007, The Journal of Neuroscience.

[35]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[36]  D. Holtzman,et al.  Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism , 2006, The Journal of Neuroscience.

[37]  Jin-Moo Lee,et al.  Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ* , 2006, Journal of Biological Chemistry.

[38]  E. Lo,et al.  Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke , 2006, Stroke.

[39]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[40]  Eric E. Smith,et al.  Cerebral amyloid angiopathy and lobar intracerebral hemorrhage. , 2006, Archives of neurology.

[41]  J. Attems.  Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms , 2005, Acta Neuropathologica.

[42]  K. Jellinger,et al.  Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy , 2005, Acta Neuropathologica.

[43]  Jian Xu,et al.  Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage , 2005, Journal of the Neurological Sciences.

[44]  E. Otomo,et al.  Cerebral amyloid angiopathy in the aged , 1987, Journal of Neurology.

[45]  D. Holtzman,et al.  Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy , 2003, Annals of neurology.

[46]  D. Corbett,et al.  Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases , 2003, Annals of neurology.

[47]  J. Arenillas,et al.  Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke , 2003, Circulation.

[48]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[49]  G. Butler,et al.  Human Tissue Inhibitor of Metalloproteinases 3 Interacts with Both the N- and C-terminal Domains of Gelatinases A and B , 1999, The Journal of Biological Chemistry.

[50]  C. Zarow,et al.  Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss. , 1999, Alzheimer disease and associated disorders.

[51]  Michael J. Cullen,et al.  Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40) , 1996, The Journal of Neuroscience.

[52]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[53]  P. Gottschall,et al.  Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides , 1996 .

[54]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[55]  M. Esiri,et al.  Cerebral amyloid angiopathy in dementia and old age. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[56]  H. Vinters,et al.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.

[57]  T. Mandybur.  The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.